CRYSTALGENOMICS, INC.
10Patents
9Active
10Granted
44Portfolio score
Filing activity: Jan 20, 2004 → Feb 14, 2020 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9758508B2 | 2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same | Chemistry; Metallurgy | 25 | Active |
| US7973060B2 | Fab I inhibitor and process for preparing same | Chemistry; Metallurgy | 4 | Active |
| US10604508B2 | 2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same | Chemistry; Metallurgy | 0 | Active |
| US11602517B2 | Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment of pain | Human Necessities | 0 | Active |
| US11230539B2 | 2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same | Chemistry; Metallurgy | 0 | Active |
| US8053435B2 | Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same | Chemistry; Metallurgy | 0 | Active |
| US11655207B2 | Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxy amide or of derivative thereof and method for preparing same | Chemistry; Metallurgy | 0 | Active |
| US8119812B2 | Thiazolidinone derivative | Chemistry; Metallurgy | 0 | Active |
| US7179832B2 | Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereof | Chemistry; Metallurgy | 0 | Expired |
| US10413520B2 | Oral pharmacological composition including 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone having crystalline structure with excellent stability | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.